Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Vivaglobin
BIOLOGICAL
2 trials
Sponsors
CSL Behring
Conditions
Agammaglobulinemia
Common Variable Immunodeficiency
Multifocal Motor Neuropathy (MMN)
Phase 2
A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
Completed
NCT00701662
CSL Behring
Multifocal Motor Neuropathy (MMN)
Start: 2007-11-30
End: 2009-01-31
Updated: 2013-08-01
Phase 4
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
Completed
NCT00520494
CSL Behring
Agammaglobulinemia, Common Variable Immunodeficiency
Start: 2007-03-31
End: 2008-10-31
Updated: 2013-06-20
Related Papers
A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
2011-06-01
60 citations